The following guideline can be ordered through the address listed in the "Source/Publisher"-category. In cases in which you can order through the Internet we have established a hyperlink.

FDA Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs

Origin/Publisher:

FDA

Content:
This guidance recommends steps manufacturers of APIs and drug products should take to detectand prevent unacceptable levels of nitrosamine2 impurities in pharmaceutical products

Go back

GMP Conferences by Topics